Bottom line
XLV vs PHLAX: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PHLAX (PGIM Jennison Health Sciences Fund) share a meaningful slice of their top holdings — about 50% by weight.
XLV is cheaper at 0.08% vs 1.15% — a difference of $107 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +5.5% for PHLAX (reporting dates differ).
PHLAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
XLV vs PHLAX side by side
| XLV | PHLAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | PGIM (Prudential) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 1.15% |
| Annual cost per $10k | $8 | $115 |
| 10-yr cost on $10k (prospectus) | $103 | $1,871 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0.02% | 0.3% |
| 1-yr return | +14.5% | +12.7% |
| 5-yr return (annualized) | +8.1% | +5.5% |
| 10-yr return (annualized) | +9.8% | +8.9% |
| Best quarter | +14.5% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $40.6B | $1.4B |
| Number of holdings | 65 | 55 |
| Portfolio turnover | 2% | 81% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of XLV's top 25 holdings also appear in PHLAX's top 25.
| Holding | XLV | PHLAX |
|---|---|---|
| Eli Lilly & Co | 16.51% | 17.35% |
| UnitedHealth Group Inc | 6.57% | 5.87% |
| Merck & Co Inc | 5.52% | 6.06% |
| Thermo Fisher Scientific Inc | 3.24% | 4.56% |
| Intuitive Surgical Inc | 2.45% | 3.07% |
| CVS Health Corp | 2.30% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.19% | 3.37% |
| Danaher Corp | 2.09% | 3.28% |
| Stryker Corp | 1.89% | 2.16% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
PHLAX top 10
- Eli Lilly & Company — 17.35%
- Merck & Company Inc — 6.06%
- Unitedhealth Group Inc — 5.87%
- Thermo Fisher Scientific Inc — 4.56%
- Argenx Se — 3.55%
- Vertex Pharmaceuticals Inc — 3.37%
- Danaher Corp — 3.28%
- Intuitive Surgical Inc — 3.07%
- Lonza Group Ag — 3.02%
- Cvs Health Corp — 2.52%
FAQ
What is the difference between XLV and PHLAX?
Which is cheaper, XLV or PHLAX?
Should I own both XLV and PHLAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.